Banghulot, Donna Marie .

HRN: 21-39-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
CEFTAZIDIME 1GM (VIAL)
07/13/2022
07/20/2022
IV
117mg
Q8H
NEONATAL PNEUMONIA
Waiting Final Action 
07/14/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2022
07/20/2022
IVT
50mg
Od X 7 Days
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: